These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25280290)

  • 21. [Absence of precipitating effect of uric acid on calcium oxalate].
    Pinto B; Vives JA; Soler Roselló A
    Actas Urol Esp; 1985; 9(3):221-4. PubMed ID: 4036686
    [No Abstract]   [Full Text] [Related]  

  • 22. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can a Simplified 12-Hour Nighttime Urine Collection Predict Urinary Stone Risk?
    Hinck BD; Ganesan V; Tarplin S; Asplin J; Granja I; Calle J; Sivalingam S; Monga M
    Urology; 2017 Oct; 108():40-45. PubMed ID: 28705575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
    Cheungpasitporn W; Erickson SB; Rule AD; Enders F; Lieske JC
    J Urol; 2016 May; 195(5):1476-1481. PubMed ID: 26598423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stress and risk of urolith formation. I. The influence of stress on lithogenous urinary substances (author's transl)].
    Brundig P; Berg W; Schneider HJ
    Urol Int; 1981; 36(3):199-207. PubMed ID: 7281375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary inhibitory activity of calcium oxalate monohydrate crystal growth in stone-formers & non stone-formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Rattan V; Thind SK; Nath R; Malakondaiah GC; Tandon SP
    Indian J Med Res; 1987 Oct; 86():500-5. PubMed ID: 3443483
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A; Montanari E
    Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nephrolithiasis in patients with intestinal diseases].
    Cirillo M; Iudici M; Marcarelli F; Laudato M; Zincone F
    G Ital Nefrol; 2008; 25(1):42-8. PubMed ID: 18264917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the medical management of stone disease.
    Tracy CR; Pearle MS
    Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperuricosuria and calcium nephrolithiasis.
    Coe FL; Parks JH
    Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958
    [No Abstract]   [Full Text] [Related]  

  • 33. Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors.
    Kleinman JG
    Kidney Int; 2007 Jul; 72(1):8-10. PubMed ID: 17597787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium oxalate crystallization index (COCI): an alternative method for distinguishing nephrolithiasis patients from healthy individuals.
    Yang B; Dissayabutra T; Ungjaroenwathana W; Tosukhowong P; Srisa-Art M; Supaprom T; Insin N; Boonla C
    Ann Clin Lab Sci; 2014; 44(3):262-71. PubMed ID: 25117095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related changes in 24-hour urine composition must be considered in the medical management of nephrolithiasis.
    Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
    J Endourol; 2014 Jul; 28(7):871-6. PubMed ID: 24571654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [EXPERIENCE OF USE OF BLEMAREN® IN THE TREATMENT OF PATIENTS IN URIC ACID AND CALCIUM OXALATE UROLITHIASIS].
    Konstantinova OV; Yanenko EK
    Urologiia; 2015; (5):22-4, 26. PubMed ID: 26859932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Uric acid nephrolithiasis].
    Ferraro PM; Gambaro G
    G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.
    Bell DS
    Diabetes Obes Metab; 2012 Apr; 14(4):299-303. PubMed ID: 21992452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.